Select your country
Select a country to go to the website of the respective STADA sales company.
Czech Republic (1)
United Kingdom (4)
STADA records satisfactory development in the first nine months of 2013 – sales growth of 8 percent – adjusted EBITDA margin at 19.8 percent…
STADA expands biosimilar range and in-licenses filgrastim product from Apotex Inc.
Foregoing the use of external consultants brings millions in savings:
STADA establishes IT shared service center for the Group
STADA expands diagnostics portfolio:
New user-friendly self-tests for five areas of indication
STADA website in new guise: Quicker access to the right information with a new design and smartphone optimization
Viagra active ingredient patent expiration: STADA Group launches low-cost alternative in the market to treat erectile dysfunction
Main sponsor STADA celebrates with the RSV Lahn-Dill: Wheelchair basketball team concludes successful season
STADA: Dr. Matthias Wiedenfels to become Chief Corporate Development and Central Services Officer –
STADA's Executive Board expanded to four …
With "STADA Diagnostik" STADA is entering the personalized drug therapy business